This session will focus on how the opioid epidemic has affected pregnant women and their infants and how public health approaches can improve outcomes for the maternal-infant dyad. There has been a four-fold increase in the number of pregnant women with opioid use disorder in the United States over the last decade. Still, pregnant women have difficulty accessing treatment and even those who do are frequently not treated with evidence-based treatments like opioid agonist therapies. Similarly, the number of infants diagnosed with neonatal abstinence syndrome, an opioid withdrawal syndrome that occurs shortly after birth, grew nearly seven-fold over the last decade, yet care across the United States is uneven, resulting in uneven outcomes.
In this session, presenters will discuss public health and family-centered approaches to caring for pregnant women and infants affected by the opioid epidemic. They will highlight the complex partnerships that must be formed to ensure best outcomes, including from addiction medicine, women’s health, pediatric medicine, child welfare, and early intervention services. They will focus on innovative solutions being trialed across the country to improve outcomes for this vulnerable population.
This session is accredited for the following accreditation types: CME, CNE, CPE, APA, AAFP, AAHCPAD*, NAADAC*, ASWB*
*State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit.